Kalin Katherine Bach bought SLS
January 7, 2026 · Form 4 insider transaction
Kalin Katherine Bach bought 50,000 shares of SELLAS Life Sciences Group, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$0.00
Total value
N/A
InsiderKalin Katherine Bach
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 7, 2026
Filing dateJanuary 9, 2026
Shares owned after154,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.